Deciphering Tumour Heterogeneity: From Tissue to Liquid Biopsy

Pauline Gilson(Centre National de la Recherche Scientifique), Alexandre Harlé(Centre National de la Recherche Scientifique)

Cancers

March 8, 2022

10.3390/cancers14061384

Cited by 108

Related Papers

Dépistage du déficit en dihydropyrimidine déshydrogénase (DPD) et sécurisation des chimiothérapies à base de fluoropyrimidines : mise au point et recommandations nationales du GPCO-Unicancer et du RNPGx

|Bulletin du Cancer|2018|108

Representative Sequencing: Unbiased Sampling of Solid Tumor Tissue

|Cell Reports|2020|77

Beside P53 and PTEN: Identification of molecular alterations of the RAS/MAPK and PI3K/AKT signaling pathways in high-grade serous ovarian carcinomas to determine potential novel therapeutic targets

|Oncology Letters|2016|20

579P A multicenter evaluation of a low pass whole genome sequencing-based solution for homologous recombination deficiency detection

|Annals of Oncology|2022|1